Correlation Between Q32 Bio and DiaMedica Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Q32 Bio and DiaMedica Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Q32 Bio and DiaMedica Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Q32 Bio and DiaMedica Therapeutics, you can compare the effects of market volatilities on Q32 Bio and DiaMedica Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Q32 Bio with a short position of DiaMedica Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Q32 Bio and DiaMedica Therapeutics.

Diversification Opportunities for Q32 Bio and DiaMedica Therapeutics

-0.4
  Correlation Coefficient

Very good diversification

The 3 months correlation between Q32 and DiaMedica is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Q32 Bio and DiaMedica Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DiaMedica Therapeutics and Q32 Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Q32 Bio are associated (or correlated) with DiaMedica Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DiaMedica Therapeutics has no effect on the direction of Q32 Bio i.e., Q32 Bio and DiaMedica Therapeutics go up and down completely randomly.

Pair Corralation between Q32 Bio and DiaMedica Therapeutics

Given the investment horizon of 90 days Q32 Bio is expected to generate 1.18 times more return on investment than DiaMedica Therapeutics. However, Q32 Bio is 1.18 times more volatile than DiaMedica Therapeutics. It trades about 0.1 of its potential returns per unit of risk. DiaMedica Therapeutics is currently generating about 0.08 per unit of risk. If you would invest  958.00  in Q32 Bio on September 4, 2024 and sell it today you would earn a total of  1,518  from holding Q32 Bio or generate 158.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Q32 Bio  vs.  DiaMedica Therapeutics

 Performance 
       Timeline  
Q32 Bio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Q32 Bio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
DiaMedica Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Q32 Bio and DiaMedica Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Q32 Bio and DiaMedica Therapeutics

The main advantage of trading using opposite Q32 Bio and DiaMedica Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Q32 Bio position performs unexpectedly, DiaMedica Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DiaMedica Therapeutics will offset losses from the drop in DiaMedica Therapeutics' long position.
The idea behind Q32 Bio and DiaMedica Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Commodity Directory
Find actively traded commodities issued by global exchanges